EMA officials discuss expedited approval pathways, scientific advice mechanisms
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyClinical Trials Regulation EuropeEuropean Medicines Agency (EMA)Health Authority meeting and communication strategyPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy